RIGI and non-small cell lung carcinoma: To further verify whether circNDUFB2 inhibits NSCLC progression via destabilizing IGF2BPs and activating innate immunity, we performed colony formation assays as well as migration and invasion assays to measure the restoring effects of IGF2BPs and RIG-I on A549 cells.